Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Isotope tracing reveals distinct substrate preference in murine melanoma subtypes with differing anti-tumor immunity. | Cancer Metab | 2022 | 36457136 | PubTator, text mining | PubMed |
| TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development. | Int J Mol Sci | 2022 | 36430910 | PubTator, text mining | PubMed |
| Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets. | Int J Mol Sci | 2022 | 36430837 | PubTator, text mining | PubMed |
| Amino Acids in Cancer and Cachexia: An Integrated View. | Cancers (Basel) | 2022 | 36428783 | PubTator, text mining | PubMed |
| Predictive markers for efficiency of the amino-acid deprivation therapies in cancer. | Front Med (Lausanne) | 2022 | 36405587 | PubTator, text mining | PubMed |
| Parkinson disease-associated Leucine-rich repeat kinase regulates UNC-104-dependent axonal transport of Arl8-positive vesicles in Drosophila. | iScience | 2022 | 36404922 | PubTator, text mining | PubMed |
| Profiling mRNA, miRNA and lncRNA expression changes in endothelial cells in response to increasing doses of ionizing radiation. | Sci Rep | 2022 | 36402833 | PubTator, text mining | PubMed |
| Prescreening of tumor samples for tumor-centric transcriptome analyses of lung adenocarcinoma. | BMC Cancer | 2022 | 36397035 | PubTator, text mining | PubMed |
| Insight into the potential role of ferroptosis in neurodegenerative diseases. | Front Cell Neurosci | 2022 | 36385946 | PubTator, text mining | PubMed |
| A human kidney and liver organoid-based multi-organ-on-a-chip model to study the therapeutic effects and biodistribution of mesenchymal stromal cell-derived extracellular vesicles. | J Extracell Vesicles | 2022 | 36382606 | PubTator, text mining | PubMed |
| Biotechnological Intervention and Secondary Metabolite Production in Centella asiatica L. | Plants (Basel) | 2022 | 36365380 | PubTator, text mining | PubMed |
| Iron Compounds in Anaerobic Degradation of Petroleum Hydrocarbons: A Review. | Microorganisms | 2022 | 36363734 | PubTator, text mining | PubMed |
| The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma. | Int J Mol Sci | 2022 | 36362209 | PubTator, text mining | PubMed |
| Identification of Clinical Variants beyond the Exome in Inborn Errors of Metabolism. | Int J Mol Sci | 2022 | 36361642 | PubTator, text mining | PubMed |
| Antagonization of OX1 Receptor Potentiates CB2 Receptor Function in Microglia from APPSw/Ind Mice Model. | Int J Mol Sci | 2022 | 36361598 | PubTator, text mining | PubMed |
| Single Cell Analysis of Gastric Cancer Reveals Non-Defined Telomere Maintenance Mechanism. | Cells | 2022 | 36359738 | PubTator, text mining | PubMed |
| Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer. | Biomolecules | 2022 | 36358940 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe. | Cancers (Basel) | 2022 | 36358770 | PubTator, text mining | PubMed |
| Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy. | Cancers (Basel) | 2022 | 36358687 | PubTator, text mining | PubMed |
| The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer's Disease: Therapeutic Implications and Future Perspectives. | Antioxidants (Basel) | 2022 | 36358538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=30